Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when GridAI Technologies Corp. publishes a filing, an earnings call transcript or a press release.

Get GRDX alerts

About Jack Syage, PhD.

Jack Syage, PhD. is recorded as COO at GridAI Technologies Corp. (GRDX) since March 13, 2024. GridAI Technologies Corp. reported in an 8-K filed March 25, 2025 that Jack Syage, PhD. resigned as a current director. GridAI Technologies Corp. reported in an 8-K filed July 23, 2024 that Jack Syage, PhD. resigned as Chief Scientific Officer, effective July 17, 2024. GridAI Technologies Corp. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at GridAI Technologies Corp. includes Jason D. Sawyer (CEO), Richard Joel Paolone (CEO, Chairman and Board Member), Anna Skowron (CFO) and 7 others.

“Pursuant to the Rescission Agreement referenced in Item 1.01 above, Mr. Syage is expected to resign from all positions with the Company upon the closing of the Proposed Recission.”
GridAI Technologies Corp. Form 8-K, filed March 25, 2025 · Read the filing
“On July 17, 2024, the Board of Directors (the "Board") of Entero Therapeutics, Inc. (the "Company"), received a letter (the "Letter") from Dr. Jack Syage, the Company's Chief Scientific Officer, President and member of the Board, whereby he tendered his resignation from the role of Chief Scientific Officer of the Company, effective immediately.”
GridAI Technologies Corp. Form 8-K, filed July 23, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at GridAI Technologies Corp.

Recent activity